Login to Your Account

Disconnect or innovation? Lawmakers question Medicare demonstrations

By Mari Serebrov
Regulatory Editor

Wednesday, September 7, 2016

The need to rein in the escalating cost of health care in the U.S. collided Wednesday with concerns about separation of powers, the objectivity of the CBO, and the scope and real-world impact of a proposed Medicare Part B drug demonstration project.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription